Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe three licensed injection sites for Mounjaro (tirzepatide) are the abdomen, the front or outer thigh, and the upper arm — each giving reliable absorption when used correctly. Knowing exactly where to inject, and how to rotate between sites, is one of the most practical decisions you make when starting treatment. This guide walks through each site clearly, based on the guidance in the NHS tirzepatide medicines page and the medicine's Summary of Product Characteristics. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically suitable before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture three zones on your body: a rough rectangle across your lower abdomen, a strip along the front and outer face of each thigh, and the fleshy back-of-the-arm area roughly midway between shoulder and elbow. Those three zones are where Mounjaro is designed to go. The KwikPen pushes a small, fine needle just beneath the skin surface, into subcutaneous fat, not into muscle. That matters, because a muscular injection changes how quickly the medicine absorbs and can cause more discomfort.
The abdomen is the most commonly chosen starting point because it has a reliable layer of subcutaneous tissue in most adults and is easy to reach alone. Avoid injecting within about 5 cm of the navel, the tissue there is firmer and less suitable. Thighs work well too, particularly the front or outer face; the inner thigh and the area near the knee are off-limits. The upper arm is a little harder to self-inject but entirely appropriate if you have help, or if you practise the technique your prescriber demonstrates.
If you are on Mounjaro injections and want a more detailed visual reference for each site, the injection site pictures page illustrates the correct zones with annotated diagrams.
Injecting into the same small patch of skin week after week causes a problem called lipohypertrophy, a build-up of scar-like fatty tissue that looks like a firm lump under the skin and, crucially, reduces absorption of the medicine. You might be injecting at the right dose while getting an unpredictable amount into your system. Rotation prevents this.
A practical system: think of the abdomen as a clock face. One week inject at 12 o'clock, well above the navel zone; the next at 3 o'clock to the right; then 6 o'clock below; then 9 o'clock to the left. Alternatively, alternate between body areas entirely, abdomen one week, right thigh the next, left thigh the week after. Neither approach is wrong; the one you remember and actually do is the right one.
Some people find it easier to keep a simple note on their phone, or to stick a small dot of tape on the fridge door next to where they store the pen, to remind them which site they used last. Small systems work. Ask your prescriber if you need help designing a rotation schedule that suits your routine, they hear this question often.
Once you have chosen your site for this injection, a few consistent habits keep the process clean and comfortable. Clean the area with an alcohol swab and let it dry fully, injecting through damp skin stings more than it needs to. Pinching the skin gently before pressing the pen gives the needle a clear path into subcutaneous tissue, which is particularly helpful for anyone with a lower body-fat percentage in that area.
Press the pen firmly against the skin, press the button, and hold for the full count recommended in your Patient Information Leaflet, releasing too early means part of the dose stays in the pen. After the injection, press gently with a cotton ball or dry swab if there is any bleeding; do not rub, as rubbing disperses the medicine unevenly.
Needle-change is not optional between injections either. A used needle becomes blunt, blunt needles go through skin with more force and more pain. If you need replacement pen needles, they are available separately. Once finished, the used needle goes directly into a sharps container, not a household bin. Your local pharmacy or GP surgery can advise on collection schemes.
For a closer read on arm-specific technique, the upper-arm injection guide covers positioning and the self-injection angles that work best.
Some redness, mild swelling or brief tenderness at the injection spot is normal and usually fades within a day or two, this is a standard inflammatory response to a foreign substance under the skin. It is worth keeping a mental note of where you injected if you notice persistent redness, a hard lump, or itching that does not settle.
Skin reactions that are spreading, lasting more than a few days, or accompanied by warmth and pain need a clinical eye. So does any generalised rash or swelling that goes beyond the injection site, that pattern can indicate a hypersensitivity reaction rather than a local skin response, and your prescriber needs to know. The MHRA's Yellow Card scheme exists for reporting unexpected reactions, and your prescriber can submit a report on your behalf if needed.
If you have had persistent problems with a specific site, sometimes the answer is simply to retire that zone for a few weeks. Your prescriber can talk through what is happening and whether your rotation pattern needs adjusting. You can also read our guide covering where to inject Mounjaro for a clear summary of suitable sites, browse commonly asked questions about Mounjaro technique, or reach out directly through our contact page if something does not feel right between scheduled reviews.
If you are still deciding whether Mounjaro is the right route for you, the weight-loss treatments overview sets out the options clearly. When you are ready, speak to our prescribers through a free consultation, a named clinician reviews your answers the same day. Patients who prefer a more conversational walkthrough may also find our plain-language page on where you inject Mounjaro a helpful starting point, and those using the KwikPen for the first time can check the pen-specific injection site guidance before their first dose.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.